How do US physicians rate therapies for type 2 diabetes mellitus (T2DM)? When 100 US-based diabetologists and primary care physicians rated treatment options last year, it was a close race for first place, as Humalog only ranked one point higher than second place Victoza, in terms of overall brand satisfaction. (See Table 1).
Table 1: T2DM therapies ranked by US physicians for brand satisfaction
Based on the Net Promoter Score (NPS) system, eight out of 11 brands featured in the 2017 survey received positive scores. The scores indicate that brand health differs greatly across the available therapies. Due to the growing number of diabetes treatment options on the market, the 2018 surveys will be broken down into two categories, injectable and oral medications. Responses to the latest T2DM injectables survey will be available in the coming weeks and will show how this market is ranked by US physicians (click here to be notified when results are available).
Table 2: Brands included in the upcoming T2DM injectables 2018 survey
FirstWord has conducted similar research in 15 competitive disease areas across the US and EU. Contact us to learn more.
To read more Sponsored Story articles, click here.